Barbara Kosacz

Insider Reports History

Entity
Individual
Location
3175 Hanover Street, Palo Alto, CA
Signature
/s/ Mark Worthington, Attorney in fact for Barbara Kosacz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Barbara Kosacz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kronos Bio, Inc. COO & General Counsel Common Stock 929K $1.1M $1.18 Jan 4, 2024 Direct
PHOENIX BIOTECH ACQUISITION CORP. Director Class A Common Stock 5.83K $58.3K $10.00 Feb 14, 2024 Direct
Kronos Bio, Inc. COO & General Counsel Employee Stock Option (Right to Buy) 208K Feb 15, 2023 Direct
Athira Pharma, Inc. Director Stock Option (Right to Buy) 20.9K May 24, 2024 Direct
XOMA Corp Director Non-Qualified Share Option (right to buy) 9.76K May 15, 2024 Direct

Insider Reports Filed by Barbara Kosacz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATHA Athira Pharma, Inc. May 24, 2024 1 $0 4 May 24, 2024 Director
XOMA XOMA Corp May 15, 2024 1 $0 4 May 17, 2024 Director
CERO PHOENIX BIOTECH ACQUISITION CORP. Feb 14, 2024 1 $0 4 Feb 16, 2024 Director
KRON Kronos Bio, Inc. Jan 4, 2024 1 -$12.6K 4 Jan 5, 2024 COO & General Counsel
ATHA Athira Pharma, Inc. May 19, 2023 1 $0 4 May 22, 2023 Director
XOMA XOMA Corp May 17, 2023 1 $0 4 May 19, 2023 Director
KRON Kronos Bio, Inc. Feb 15, 2023 2 $0 4 Feb 17, 2023 COO & General Counsel
KRON Kronos Bio, Inc. Jul 25, 2022 1 $0 4 Jul 27, 2022 COO & General Counsel
ATHA Athira Pharma, Inc. May 20, 2022 1 $0 4 May 27, 2022 Director
XOMA XOMA Corp May 18, 2022 1 $0 4 May 20, 2022 Director
KRON Kronos Bio, Inc. Feb 15, 2022 2 $0 4 Feb 17, 2022 COO & General Counsel
PBAX PHOENIX BIOTECH ACQUISITION CORP. Oct 8, 2021 1 $0 4 Oct 12, 2021 Director
PBAX PHOENIX BIOTECH ACQUISITION CORP. Oct 5, 2021 0 $0 3 Oct 5, 2021 Director
XOMA XOMA Corp May 19, 2021 1 $0 4 May 21, 2021 Director